Abstract
This chapter presents an overview of access pathways to high-cost medicines in Australia, including funding and pricing processes for medicines subsidised by the national pharmaceutical insurance system, the Pharmaceutical Benefits Scheme (PBS) as well as other avenues for accessing non-PBS-funded medicines. It describes current and emerging policies for facilitating access to high-cost medicines by providing better information of the public and improving engagement in decision-making.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.